跳至主要内容
临床试验/EUCTR2005-002958-21-HU
EUCTR2005-002958-21-HU进行中(未招募)不适用

The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drugs

Sanofi-Synthelabo Rt.0 个研究点开始时间: 2005年7月7日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age between 40 and 65 years
  • Both gender
  • Type 2 diabetes mellitus
  • Combined oral antidiabetic treatment (biguanid + sulfanylurea)
  • BMI>25 kg/m2, <30 kg/m2
  • HbA1c>7.0% - <9.0% within one month
  • Signed Informed consent
  • Are the trial subjects under 18?
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Type 1 diabetes mellitus
  • known malignancy
  • drug or alcohol abuse
  • severe liver disease
  • renal faliure (se kreatinin> 150 micromol/l)
  • pregnancy, planned pregnancy, brest feeding

研究者

发起方
Sanofi-Synthelabo Rt.

相似试验

The determination of the exact time of... | 临床试验